Effects of dopamine agonists. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy17

Corpus Striatum Nucleus Accumbens Substantia Nigra Entopeduncular Nucleus Neurons Brain Limbic System Neostriatum Dopaminergic Neurons Basal Ganglia Ventral Tegmental Area Mesencephalon Caudate Nucleus Putamen Prefrontal Cortex Pituitary Gland Cells, Cultured

Organisms6

Rats, Sprague-Dawley Claviceps Rats, Wistar Rats, Inbred Strains Animals, Newborn Mice, Inbred C57BL

Diseases16

Prolactinoma Hyperprolactinemia Parkinson Disease Pituitary Neoplasms Restless Legs Syndrome Psychoses, Substance-Induced Dyskinesia, Drug-Induced Galactorrhea Acromegaly Parkinson Disease, Secondary Parkinsonian Disorders Adenoma Heart Valve Diseases Disease Models, Animal Ovarian Hyperstimulation Syndrome Catalepsy

Chemicals and Drugs102

Dopamine Agonists Dopamine Ergolines Receptors, Dopamine D2 Pergolide Receptors, Dopamine Bromocriptine Receptors, Dopamine D1 Dopamine Antagonists Benzothiazoles Receptors, Dopamine D3 Apomorphine Dopamine Agents Quinpirole Antiparkinson Agents Lisuride 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine Levodopa Piribedil Dopamine Plasma Membrane Transport Proteins Benzazepines Dopamine Uptake Inhibitors Hydroxydopamines Domperidone Tetrahydronaphthalenes Spiperone Oxidopamine Haloperidol Receptors, Dopamine D5 Prolactin Sulpiride alpha-Methyltyrosine Dopamine beta-Hydroxylase Carbidopa Amphetamine Serotonin 5-HT2 Receptor Agonists Cocaine Pimozide Dextroamphetamine Deoxyepinephrine Raclopride Ergotamine Aminoquinolines RNA Isoforms Pyrrolidines Monoamine Oxidase Inhibitors GABA Agonists Salicylamides 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Central Nervous System Stimulants Metoclopramide Antipsychotic Agents Thiophenes Indoles Amantadine Nicotinic Agonists Tyrosine 3-Monooxygenase Homovanillic Acid Fenoldopam Purinergic P1 Receptor Agonists Dopamine and cAMP-Regulated Phosphoprotein 32 Piperazines Muscarinic Agonists Somatostatin Adrenergic Agonists Receptors, Somatostatin Thiazoles Serotonin 5-HT1 Receptor Agonists Serotonin Adrenergic alpha-2 Receptor Agonists Histamine Agonists Norepinephrine Tropanes Flupenthixol Nomifensine Adrenergic beta-Agonists Dihydroxyphenylalanine Purinergic P2 Receptor Agonists GABA-A Receptor Agonists Excitatory Amino Acid Agonists Cholinergic Agonists Adrenergic alpha-Agonists Methamphetamine Vesicular Monoamine Transport Proteins Adenosine A1 Receptor Agonists Human Growth Hormone Butaclamol Receptors, Opioid, mu Cyclic AMP Biogenic Monoamines Adrenergic alpha-1 Receptor Agonists Catecholamines Serotonin Antagonists Receptors, Opioid, kappa Ligands Cannabinoid Receptor Agonists Piperidines Reserpine GABA-B Receptor Agonists Phenethylamines Calcium Adrenergic beta-3 Receptor Agonists

Analytical, Diagnostic and Therapeutic Techniques and Equipment12

Startle Reaction Microdialysis Analysis of Variance Microinjections Radioligand Assay Deep Brain Stimulation Double-Blind Method Disease Models, Animal Drug Therapy, Combination Binding, Competitive Self Administration Electric Stimulation

Psychiatry and Psychology15

Impulse Control Disorders Restless Legs Syndrome Psychoses, Substance-Induced Gambling Behavior, Animal Motor Activity Startle Reaction Jealousy Reward Compulsive Behavior Impulsive Behavior Reinforcement (Psychology)Stereotyped Behavior Conditioning, Operant Reaction Time

Phenomena and Processes10

Dose-Response Relationship, Drug Motor Activity Startle Reaction Drug Interactions Time Factors Synaptic Transmission Signal Transduction Binding, Competitive Brain Chemistry Reaction Time

Health Care2

Analysis of Variance Double-Blind Method

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Health Care

Dopamine Agonists Dopamine Ergolines Receptors, Dopamine D2 Pergolide Receptors, Dopamine Bromocriptine Receptors, Dopamine D1 Dopamine Antagonists Benzothiazoles Receptors, Dopamine D3 Apomorphine Dopamine Agents Quinpirole Antiparkinson Agents Prolactinoma Lisuride 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine Levodopa Piribedil Dopamine Plasma Membrane Transport Proteins Benzazepines Hyperprolactinemia Parkinson Disease Impulse Control Disorders Corpus Striatum Dopamine Uptake Inhibitors Hydroxydopamines Domperidone Pituitary Neoplasms Tetrahydronaphthalenes Spiperone Oxidopamine Haloperidol Receptors, Dopamine D5 Restless Legs Syndrome Prolactin Sulpiride Psychoses, Substance-Induced alpha-Methyltyrosine Dose-Response Relationship, Drug Gambling Dyskinesia, Drug-Induced Dopamine beta-Hydroxylase Carbidopa Amphetamine Serotonin 5-HT2 Receptor Agonists Nucleus Accumbens Behavior, Animal Cocaine Pimozide Rats, Sprague-Dawley Galactorrhea Motor Activity Startle Reaction Dextroamphetamine Deoxyepinephrine Substantia Nigra Entopeduncular Nucleus Jealousy Acromegaly Claviceps Reward Raclopride Ergotamine Aminoquinolines Compulsive Behavior Parkinson Disease, Secondary RNA Isoforms Neurons Pyrrolidines Monoamine Oxidase Inhibitors GABA Agonists Brain Salicylamides Limbic System Neostriatum 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Central Nervous System Stimulants Parkinsonian Disorders Metoclopramide Rats, Wistar Antipsychotic Agents Thiophenes Indoles Drug Interactions Rats, Inbred Strains Microdialysis Amantadine Dopaminergic Neurons Nicotinic Agonists Tyrosine 3-Monooxygenase Homovanillic Acid Fenoldopam Time Factors Purinergic P1 Receptor Agonists Dopamine and cAMP-Regulated Phosphoprotein 32 Analysis of Variance Basal Ganglia Microinjections

No FAQ available that match "effects of dopamine agonists"